搜索
Aerovate Therapeutics Inc
AVTE添加自选
2.680USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
77.68M总市值
亏损市盈率 TTM
关于 Aerovate Therapeutics Inc 公司
Aerovate Therapeutics Inc. 是一家临床阶段的生物制药公司。该公司专注于开发能够显著改善罕见心肺疾病患者生活的药物。其最初的重点是推进 AV-101，这是一种用于治疗肺动脉高压 (PAH) 的伊马替尼干粉吸入剂型，这是一种影响美国和欧洲约 70,000 人的毁灭性疾病。口服伊马替尼在 PAH 患者的主要终点、六分钟步行距离和多个次要血流动力学终点方面也表现出统计学上的显著改善。AV-101 使用干粉吸入器输送，旨在提供等于或高于口服剂量的肺部浓度，同时限制药物的全身水平。PAH 是一种医疗需求尚未得到满足的罕见病，其特征是将血液从心脏右侧输送到肺部的血管压力较高。
Aerovate Therapeutics Inc简介
公司代码AVTE
公司名称Aerovate Therapeutics Inc
上市日期- -
CEOMr. Timothy P. Noyes
员工数量- -
证券类型Ordinary Share
年结日- -
公司地址930 Winter Street
城市WALTHAM
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编02451
电话16174432400
网址https://www.aerovatetx.com/
公司代码AVTE
上市日期- -
CEOMr. Timothy P. Noyes
Aerovate Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+1.84%
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Mrs. Susan Fischer
Mrs. Susan Fischer
Executive Vice President - Development Operations
Executive Vice President - Development Operations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+1.84%
Mr. Bradford D. (Brad) Dahms
Mr. Bradford D. (Brad) Dahms
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
常见问题
Aerovate Therapeutics Inc的前五大股东是谁？
Aerovate Therapeutics Inc 的前五大股东如下：Dr. Benjamin T. Dake, Ph.D.
有多少机构持有Aerovate Therapeutics Inc(AVTE)的股份？
截至2026Q1，共有241家机构持有Aerovate Therapeutics Inc的股份，合计持有的股份价值约为50.10M，占公司总股份的101.53%。与2025Q4相比，机构持股有所增加，增幅为6166480.00。